A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease

This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2018.

Détails bibliographiques
Auteur principal:	Haque, Mushfiqul
Autres auteurs:	Kabir, Md. Tanvir
Format:	Project report
Langue:	English
Publié:	BRAC University 2019
Sujets:	Alzheimer’s disease Cholinesterase inhibitors NMDA antagonists Combination therapy Efficacy Cost effectiveness
Accès en ligne:	http://hdl.handle.net/10361/11070

Documents similaires

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
par: Ishrat, Nowshin
Publié: (2024)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
par: Alam, Badrul, et autres
Publié: (2016)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Flora, Sanzida Alam
Publié: (2024)

A review on artemisinin based combination therapy for the treatment of Malaria
par: Chowdhury, Amina Ferdous
Publié: (2020)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
par: Alim, Abdul
Publié: (2023)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
par: Meem, Manila
Publié: (2023)

Open source, low cost combine harvester
par: Sazim, Md. Abdullah Bin, et autres
Publié: (2019)

In-vitro preformulation studies for the development of a novel antidiabetic combination therapy involving linagliptin and dextromethorphan
par: Shishir, Tushar Ahmed
Publié: (2018)

A review on Metastatic Melanoma combination therapy Ipilimumab-Nivolumab
par: Chakraborty, Anupama
Publié: (2024)

Identification of FAP inhibitors using in silico simulation study
par: Deeba, Maliha Tasnim
Publié: (2018)

A review on potential of PARP inhibitors in the treatment of prostate cancer
par: Islam, Saidul
Publié: (2022)

Comparison of diabetes knowledge and self-efficacy in diabetes management among the urban people and the people from Garo tribe in Mymensingh division
par: Hossain, Md. Rafayat
Publié: (2020)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
par: Islam, Nahidul
Publié: (2023)

Alzheimer's disease and marriage : an intimate account /
par: Wright, Lore K.
Publié: (1993)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
par: Tabassum, Nadira
Publié: (2024)

A pragmatic approach to the analysis of a combination formulation
par: Mubtasim, Noshin, et autres
Publié: (2016)

Role of protein’s and future treatment options for Alzheimer’s Disease
par: Islam, Md. Irfath
Publié: (2023)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
par: Chowdhury, Sariya Uzrat
Publié: (2022)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Karim, Samia Binte
Publié: (2024)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
par: Shehab, Habibul Mohsin
Publié: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
par: Saha, Bithi Rani
Publié: (2023)

Efficacy and trial effectiveness of weekly and daily iron supplementation among pregnant women in rural Bangladesh: disentangling the issues
par: Ekstrom, Eva-Charlotte, et autres
Publié: (2019)

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
par: Afroza, Halima
Publié: (2024)

A systematic review on the efficacy of Fluoxetine in the management of anxiety disorders
par: Akter, Rabia
Publié: (2024)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
par: Hassan, Md. Muhtaz
Publié: (2020)

Efficacy of sertraline in the treatment of major depressive disorder smong adult population: a systematic review
par: Maha, Tasfiah Tasnim
Publié: (2024)

Emerging therapies of Alzheimer’s disease: a comprehensive review
par: Tasin, Md Abtahi
Publié: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
par: Aziz, Farhin
Publié: (2019)

Marine compounds in the treatment of Alzheimer’s disease
par: Parveen, Sanjana
Publié: (2022)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
par: Tamanna, Mst. Taskia
Publié: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
par: Afra, Sumaiya
Publié: (2022)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
par: Karim, Azrin
Publié: (2024)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
par: Oshin, Sadia Afrin
Publié: (2021)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
par: Halim, Rabea
Publié: (2022)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
par: Paul, Pulock
Publié: (2024)

An ambient assisted living system for Alzheimer’s patients
par: Abedin, Minhajul, et autres
Publié: (2023)

Exploring Alzheimer's disease prediction with XAI in various neural network models
par: Rahman, Quazi Ashikur, et autres
Publié: (2022)

Detection of alzheimer's disease using deep learning
par: Hasan, Mahmudul, et autres
Publié: (2021)

A review on adult neurogenesis in Alzheimer’s disease
par: Akter, Moriam
Publié: (2022)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
par: Mahin, Md. Tamjidur Rahman
Publié: (2024)